![F. Carsten Thiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
F. Carsten Thiel
Chief Executive Officer at
EUSA Pharma (UK) Ltd.
Profile
F.
Carsten Thiel is currently the Chief Executive Officer & Director at EUSA Pharma (UK) Ltd. He was previously the Chief Executive Officer & Director at Abeona Therapeutics, Inc. for a brief period in 2018.
He also served as the Chief Executive Officer at AMGEN GmbH and as a Director at Karyopharm Therapeutics, Inc. He was the Vice President & Head-Europe at Amgen, Inc. from 2011 to 2014 and the Executive VP & Chief Commercial Officer at Alexion Pharmaceuticals, Inc. from 2014 to 2017.
Dr. Thiel holds a doctorate degree from Max-Planck-Institute for Molecular Genetics and a graduate degree from Philipps University of Marburg.
F. Carsten Thiel active positions
| Companies | Position | Start |
|---|---|---|
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Chief Executive Officer | 2021-03-30 |
Former positions of F. Carsten Thiel
| Companies | Position | End |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 2018-11-26 |
| ABEONA THERAPEUTICS INC. | Chief Executive Officer | 2018-11-25 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-05-31 |
| AMGEN INC. | Corporate Officer/Principal | 2013-12-31 |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Chief Executive Officer | - |
Training of F. Carsten Thiel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
AMGEN GmbH
AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Health Technology |
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Distribution Services |
- Stock Market
- Insiders
- F. Carsten Thiel
